Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised four-way crossover study of generic formoterol dry powder formulations in adult asthmatic patients
2006-004979-35Phase 3Completed
- Sponsor
- Andi - Ventis
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of formoterol in asthma (4 arms), sponsored by Andi - Ventis. Primary endpoints: General safety and tolerability of new generic formoterol dry powder formulations and Clinical equivalence/comparability of bronchodilation. Started Sep 2006; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-004979-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004979-35.